As of June 21, 2025, Ra Medical Systems Inc (RMED) reports a Gross Margin of -1050.00%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Ra Medical Systems Inc's Gross Margin
Over recent years, Ra Medical Systems Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2022-12-31 | -1050.00% |
| 2021-12-31 | -6990.91% |
| 2020-12-31 | -738.61% |
| 2019-12-31 | -224.67% |
| 2018-12-31 | 32.75% |
This slight downward trend highlights how Ra Medical Systems Inc manages its operational efficiency and pricing power over time.
Comparing Ra Medical Systems Inc's Gross Margin to Peers
To better understand Ra Medical Systems Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Ra Medical Systems Inc (RMED) | -1050.00% |
| Aethlon Medical Inc (AEMD) | 7775.20% |
| Stock Trend Capital Inc (PUMP.CN) | 100.00% |
| Calmare Therapeutics Inc (CTTC) | 71.29% |
| Imaging Dynamics Co Ltd (IDL.V) | 71.22% |
| Remedent Inc (REMI) | 69.73% |
Compared to its competitors, Ra Medical Systems Inc's Gross Margin is lower than all peers, suggesting potential challenges in production costs or pricing strategy.